The peptide synthesis market is projected to achieve significant growth, with its valuation expected to rise from USD 520.0 ...

After a roller coaster ride of successes and failures, new discovery technologies and advances in manufacturing promise a brighter future for peptides in human therapy. Some 40 years after Nobel ...

BrisSynBio has two CEM Liberty Blue automated, microwave-assisted peptide synthesisers. These support Fmoc peptide synthesis of sequences from two to about fifty residues at a scale from one to about ...

Peptides are synthesized sequentially and fully automated either one at a time or queued up to 16, for example, overnight. The Peptide Builder accommodates a wide range of synthesis scales, from 50 ...

The future challenges facing this industry revolve around developing tractable routes to producing increasingly complex peptides, increasing peptide synthesis capability, and a requirement for new ...

Cartalax peptide, a bioregulator derived from cartilage tissue, has garnered significant interest in scientific communities ...

NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:ABBV), a global biopharmaceutical company with a market capitalization of $299 billion and annual revenue exceeding $55 billion, has announced the completion ...

Cell penetrating peptides expand pivotal roles in oncology, neurology, and immunotherapy, connecting specialized carriers with advanced molecular cargo, inspiring continuous R&D efforts and valuable ...

AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Nimble Therapeutics. With the completion of the acquisition, Nimble is now a part of AbbVie.